Germany to buy stake in CureVac as world races for COVID-19 vaccine

FRANKFURT/BERLIN (Reuters) – Germany will take a stake in unlisted biotech firm CureVac, which is working on a COVID-19 vaccine, Economy Minister Peter Altmaier said on Monday, confirming an earlier Reuters report. The Berlin government will acquire a 23% stak... More »